SeaSpine Holdings Corporation (NASDAQ:SPNE) is set to announce second quarter earning results on Tuesday 4th August 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, SPNE to report 2Q20 loss of $ 0.74 per share.
For the full year, analysts anticipate top line of $ 133.61 million, while looking forward to loss of $ 1.88 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 177.00 million ~ $ 181.00 million
Click Here For More Historical Outlooks Of SeaSpine Holdings Corporation
Previous Quarter Performance
SeaSpine Holdings Corporation unveiled loss for the first quarter of $ 0.48 per share, from the revenue of $ 36.11 million. The quarterly revenues decreased 0.11 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.38 per share from $ 37.86 million in revenue. The bottom line results missed street analysts by $ 0.1 or 26.32 percent, at the same time, top line results fell short of analysts by $ 1.75 million or 4.62 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of SeaSpine Holdings Corporation
Stock Performance
According to the previous trading day, closing price of SPNE was $ 10.26, representing a 155.22 % increase from the 52 week low of $ 4.02 and a 38.86 % decrease over the 52 week high of $ 16.78.
The company has a market capital of $ 279.52 million and is part of the Healthcare sector and Medical Devices industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”SPNE” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
SeaSpine Holdings Corporation will be hosting a conference call at 5:30 PM eastern time on 4th August 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.seaspine.com
SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. The company provides orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. Its orthobiologics products include demineralized bone matrices (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures.
